Treatment of cutaneous melanoma of the face by Mohs micrographic surgery

Journal of Cutaneous Medicine and Surgery

Volumn 7, Issue 1, 2003, Pages 25-30

  Bienert, Tasha N ^a   Trotter, Martin J ^b,c   Arlette, John P ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER SURGERY; CARCINOMA IN SITU; CHEMOSURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; FACE CANCER; FEMALE; FOLLOW UP; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SKIN BIOPSY; TISSUE SECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FACE; FEMALE; FROZEN SECTIONS; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOHS SURGERY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0347926365     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-002-1161-7     Document Type: Article

References (32)

1. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648.
2. Houghton A, Coit D, Bloomer W, et al. NCCN Melanoma Practice Guidelines. National Comprehensive Cancer Network, Oncology (Huntingt) 1998; 12:153-177.
3. Sober AJ, Chuang TY, Duvic M, et al. The Guidelines/Outcomes Committee. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001; 45:579-586.
4. Gaspar ZS, Dawber RP. Treatment of lentigo maligna. Australas J Dermatol 1997; 38:1-8.
5. Schmid-Wendtner MH, Brunner B, Konz B, et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J Am Acad Dermatol 2000; 43:477-482.
6. Kuflik ED, Gage AA. Cryosurgery for lentigo maligna. J Am Acad Dermatol 1994; 31:75-78.
7. Tsang RW, Liu FF, Wells W, et al. Lentigo maligna of the head and neck. Results of treatment by radiotherapy. Arch Dermatol 1994; 130:1008-1012.
8. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol 1994; 31:79-85.
9. Clayton BD, Leshin B, Hitchcock MG, et al. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg 2000; 26:671-678.
10. Stonecipher MR, Leshin B, Patrick J, et al. Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: utility of immunoperoxidase staining and supplemental vertical sections. J Am Acad Dermatol 1993; 29:589-594.
11. Johnson TM, Headington JT, Baker SR, et al. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure. J Am Acad Dermatol 1997; 37:758-764.
12. Anderson KW, Baker SR, Lowe L, et al. Treatment of head and neck melanoma, lentigo maligna subtype. A practical surgical technique. Arch Facial Plast Surg 2001; 3:202-206.
13. Cohen LM, McCall MW, Hodge SJ, et al. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections. Cancer 1994; 73:2964-2970.
14. Cohen LM, McCall MW, Zax MH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study. Dermatol Surg 1998; 24:673-677.
15. Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol 1997; 37:422-429.
16. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997; 37:236-245.
17. Price NM, Rywlin AM, Ackerman AB. Histologic criteria for the diagnosis of superficial spreading malignant melanoma: formulated on the basis of proven metastatic lesions. Cancer 1976; 38:2434-2441.
18. McCalmont TH. Melanoma and melanoma in situ: build a better diagnosis through architecture. Semin Cutan Med Surg 1997; 16:97-107.
19. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995; 33:923-936.
20. Reyes BA, Robins P. Wood's lamp and surgical margins in malignant melanoma in situ. J Dermatol Surg Oncol 1988; 14:22.
21. Arlette JP, Carruthers A, Threlfall WJ, et al. Basal cell carcinoma of the periocular region. J Cutan Med Surg 1998; 2:205-208.
22. Zitelli JA, Moy RL, Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 1991; 24:102-106.
23. Dubow BE, Ackerman AB. Malignant melanoma in situ: the evolution of a concept. Mod Pathol 1990; 13:734-744.
24. Flotte TJ, Mihm Jr MC. Lentigo maligna and malignant melanoma in situ, lentigo maligna type. Hum Pathol 1999; 30:533-536.
25. Tannous ZS, Lerner LH, Duncan LM, et al. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type. Hum Pathol 2000; 31:705-708.
26. Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987; 116:303-310.
27. Kelly JW. Following lentigo maligna may not prevent the development of life-threatening melanoma. Arch Dermatol 1992; 128:657-660.
28. Cox NH, Aitchison TC, Sirel JM, et al. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Br J Cancer 1996; 73:940-944.
29. Elwood MJ, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998; 78:276-280.
30. Gillgren P, Mansson-Brahme E, Frisell J, et al. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck - a population-based study. Acta Oncol 1999; 38:1069-1074.
31. Weyers W, Bonczkowitz M, Weyers I, et al. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. Am J Dermatopathol 1996; 18:560-566.
32. Andersen WK, Labadie RR, Bhawan J. Histopathology of solar lentigines of the face: a quantitative study. J Am Acad Dermatol 1997; 36:444-447.